Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
暂无分享,去创建一个
M Paesmans | J P Sculier | M. Paesmans | J. Sculier | J. Klastersky | R. Sergysels | P Libert | G Bureau | G Dabouis | J Thiriaux | J Michel | O Van Cutsem | R Sergysels | P Mommen | J. Thiriaux | P. Libert | G. Bureau | G. Dabouis | O. Van Cutsem | P. Mommen | J Klastersky | O. V. Cutsem | J. Michel
[1] P. Marino,et al. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta‐analysis , 1996, Cancer.
[2] O. Brodin,et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .
[3] M Paesmans,et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Paesmans,et al. A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer. , 1994, Lung cancer.
[5] J. Sculier,et al. Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Paesmans,et al. Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer , 1994 .
[7] A. Oxman,et al. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] S. Kaasa,et al. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis , 1993, The Lancet.
[9] D. Ihde,et al. Chemotherapy of Lung Cancer , 1992 .
[10] J. Sculier,et al. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Sculier,et al. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J. Sørensen,et al. Prognostic factors in inoperable adenocarcinoma of the lung: a multivariate regression analysis of 259 patients. , 1988, Cancer research.
[13] J F Lawless,et al. Regression and recursive partition strategies in the analysis of medical survival data. , 1988, Journal of clinical epidemiology.
[14] R. Simes,et al. An improved Bonferroni procedure for multiple tests of significance , 1986 .
[15] P. Rocmans,et al. A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Groshen,et al. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J R Anderson,et al. Analysis of survival by tumor response. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Cox,et al. Analysis of Survival Data. , 1985 .
[19] P. Rocmans,et al. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party. , 1983, Cancer treatment reports.
[20] W. Dixon,et al. BMDP statistical software , 1983 .
[21] L. A. Brewer. Historical notes on lung cancer before and after Graham's successful pneumonectomy in 1933. , 1982, American journal of surgery.
[22] N. Nie,et al. Statistical Package for the Social Sciences , 1970 .
[23] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .